News Agency
The Times

Senhwa Biosciences Clinical Data Abstract of Pidnarulex Accepted for Presentation at 2024 ESMO Congress

  • Written by PR Newswire
Senhwa Biosciences Clinical Data Abstract of Pidnarulex Accepted for Presentation at 2024 ESMO Congress

TAIPEI and SAN DIEGO, July 12, 2024 /PRNewswire/ -- Senhwa Biosciences' new drug Pidnarulex (CX-5461) has demonstrated efficacy in treating various solid tumors with BRCA2 or PALB2 gene defects. The abstract of this clinical trial has been selected for presentation at the 2024 European Society for Medical Oncology (ESMO) congress. This achievement...

Read more: Senhwa Biosciences Clinical Data Abstract of Pidnarulex Accepted for Presentation at 2024 ESMO...

Why Commercial Waste Management Is Important For Modern Businesses

Businesses across many industries generate large amounts of waste every day through operations, packaging, manufacturing, customer activity, and general workplace use. Many organisations now depend on professional commercial waste management services to maintain cleaner workplaces, improve operational efficiency, and support environmentally... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion